Meredith Bock1, Maya Katz2, Stefan Sillau3, Kwame Adjepong4, Kristine Yaffe5, Roman Ayele6, Zachary A Macchi3, Steven Pantilat7, Janis M Miyasaki8, Benzi Kluger9. 1. Department of Neurology, University of California, San Francisco, California, USA; San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. Electronic address: Meredith.Bock@ucsf.edu. 2. Department of Neurology, Stanford University, California, USA. 3. Department of Neurology, University of Colorado Anschutz Medical Campus, Colorado, USA. 4. Department of Neurology, University of California, San Francisco, California, USA. 5. Department of Neurology, University of Colorado Anschutz Medical Campus, Colorado, USA; Department of Psychiatry, University of California, San Francisco, California, USA; Department of Epidemiology, University of California, San Francisco, California, USA. 6. Department of Health Systems, Management and Policy, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 7. Department of Medicine, Division of Palliative Medicine at University of California, San Francisco California, USA. 8. Department of Medicine, Division of Neurology, University of Alberta, Edmonton, Canada. 9. Departments of Neurology and Medicine, Division of Palliative Care, University of Rochester, Rochester, New Year, USA.
Abstract
CONTEXT: Increasing evidence demonstrates the benefits of palliative care among individuals with Parkinson's disease and related disorders (PDRD), but the critical components that contribute to therapeutic effects are not well understood. OBJECTIVES: To determine the specific items most responsive to a palliative care intervention in PDRD and identify key correlates of improvement in patient and care partner outcomes. METHODS: The main trial was a pragmatic comparative effectiveness trial of outpatient integrated palliative care compared to standard care among participants with PDRD (NCT02533921), showing significantly higher patient QOL at six months and lower care partner burden at 12 months. We used longitudinal regression models to analyze changes in subdomains of patient QOL and care partner burden and Spearman correlations to evaluate key correlates of change scores in patient and care partner outcomes. We performed a secondary analysis of data from 210 patients and 175 care partners. RESULTS: Compared to controls, patients in the intervention reported greater improvement in perceptions of the "self as a whole" at six months (coeff = 0.22, P < 0.05) and care partners reported greater reduction in stress, anger, and loss of control at 12 months (coeff = -.40, -0.25, -0.31, P < 0.05). Positive change in numerous patient non-motor symptoms and grief correlated with improved patient QOL, reduced patient anxiety, and increased care partner spirituality. Alleviation of care partner anxiety and depression correlated with reduced care partner burden. CONCLUSION: Specific benefits of an integrated palliative approach in PDRD include improvement in patient holistic self-impressions, care partner self-efficacy, and non-motor symptoms.
CONTEXT: Increasing evidence demonstrates the benefits of palliative care among individuals with Parkinson's disease and related disorders (PDRD), but the critical components that contribute to therapeutic effects are not well understood. OBJECTIVES: To determine the specific items most responsive to a palliative care intervention in PDRD and identify key correlates of improvement in patient and care partner outcomes. METHODS: The main trial was a pragmatic comparative effectiveness trial of outpatient integrated palliative care compared to standard care among participants with PDRD (NCT02533921), showing significantly higher patient QOL at six months and lower care partner burden at 12 months. We used longitudinal regression models to analyze changes in subdomains of patient QOL and care partner burden and Spearman correlations to evaluate key correlates of change scores in patient and care partner outcomes. We performed a secondary analysis of data from 210 patients and 175 care partners. RESULTS: Compared to controls, patients in the intervention reported greater improvement in perceptions of the "self as a whole" at six months (coeff = 0.22, P < 0.05) and care partners reported greater reduction in stress, anger, and loss of control at 12 months (coeff = -.40, -0.25, -0.31, P < 0.05). Positive change in numerous patient non-motor symptoms and grief correlated with improved patient QOL, reduced patient anxiety, and increased care partner spirituality. Alleviation of care partner anxiety and depression correlated with reduced care partner burden. CONCLUSION: Specific benefits of an integrated palliative approach in PDRD include improvement in patient holistic self-impressions, care partner self-efficacy, and non-motor symptoms.
Authors: Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Maria João Forjaz; Belén Frades-Payo; Luis Agüera-Ortiz; Daniel Weintraub; Ana Riesco; Monica M Kurtis; Kallol Ray Chaudhuri Journal: Parkinsonism Relat Disord Date: 2015-04-09 Impact factor: 4.891
Authors: Benzi M Kluger; Maya Katz; Nicholas Galifianakis; Steven Z Pantilat; Jean S Kutner; Stefan Sillau; Mark Gritz; Jacqueline Jones; Diane Fairclough; Malenna Sumrall; Kirk Hall; Janis Miyasaki Journal: Contemp Clin Trials Date: 2019-02-16 Impact factor: 2.226
Authors: Andrea L Canada; Patricia E Murphy; George Fitchett; Amy H Peterman; Leslie R Schover Journal: Psychooncology Date: 2008-09 Impact factor: 3.894
Authors: Janis M Miyasaki; J Long; D Mancini; E Moro; S H Fox; A E Lang; C Marras; R Chen; A Strafella; R Arshinoff; R Ghoche; J Hui Journal: Parkinsonism Relat Disord Date: 2012-08-03 Impact factor: 4.891
Authors: Corita R Grudzen; Lynne D Richardson; Pauline N Johnson; Ming Hu; Binhuan Wang; Joanna M Ortiz; Emmett A Kistler; Angela Chen; R Sean Morrison Journal: JAMA Oncol Date: 2016-05-01 Impact factor: 33.006